-
Mashup Score: 2John Mascarenhas, MD @TischCancer @IcahnMountSinai #MPV - 2 year(s) ago
John Mascarenhas, MD from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai speaks about the U.S. FDA Approves BESREMi® (ropeginterferon
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Podcast - John Mascarenhas, MD @TischCancer @IcahnMount - 2 year(s) ago
John Mascarenhas, MD from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai speaks about the U.S. FDA Approves BESREMi® (ropeginterferon
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Podcast - U.S. FDA Approves ropeginterferon alfa-2b-njft as the Only Interferon for Adults With Polycythemia Vera John Mascarenhas, MD @TischCancer @IcahnMountSinai #MPV #BERSREMi #Cancer #Research Link to Audio: https://t.co/hsFRKiWIb7...?channelName=cancernewsupdate https://t.co/9ZBQwuuhVY
-
U.S. FDA Approves ropeginterferon alfa-2b-njft as the Only Interferon for Adults With Polycythemia Vera John Mascarenhas, MD @TischCancer @IcahnMountSinai #MPV #BERSREMi #Cancer #Research https://t.co/6kzocKBOWg https://t.co/tGSZoTtsF0